AnQlar

Dr. Jeffrey Murray is a leading expert in infectious diseases who spent almost 30 years of his career with the FDA, including as the Deputy Division Director for the Division of Antivirals, Center for Drug Evaluation and Research.

Dr. Murray has published many articles related to antivirals and served as a reviewer for the New England Journal of Medicine while at FDA. He will assist Virpax in AnQlar’s regulatory strategy and clinical trial design.